Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Compugen
Sort By
Newest First
1 / 1
1 / 1
Cancer Therapies
Computational Discoveries for Clinical Development of Novel Cancer Therapies
David Alvaro, Ph.D.; Anat Cohen-Dayag, Ph.D.
Pharma's Almanac
PAP-Q2-20-CL-014
Jul 01, 2020
FDA
Compugen Announces FDA Clearance of IND Application for COM902
Compugen
PR-M11-19-NI-003
Nov 05, 2019
Immuno-Oncology
Compugen Presents Update on COM701 Phase 1 Trial at ASCO-SITC Clinical Immuno-Oncology Symposium
Compugen
PR-M03-19-NI-006
Mar 04, 2019
Strategic Collaboration
Compugen, MedImmune to Collaborate on Bi- and Multi-Specific Antibodies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-18-NI-007
Apr 12, 2018
Cell-Line
Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics
Selexis SA
PR-M03-18-NI-045
Mar 13, 2018
Drug Development
Compugen Advances Lead Anti-TIGIT Monoclonal Antibody to Manufacturing
Nice Insight
PAO-M11-17-NI-025
Nov 16, 2017
